|
Notice:
|
|
Suspension of shipments during Golden Week Holidays: From 29 April to 13 May, deadline 16 April.
|
|
| NIG-RNAi Strains Detail |
| Request : Click the "Order" button to request for this stock |
|
| Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
| Stock ID |
3799R-3 |
| Symbol |
Exn |
Full Name |
Ephexin |
| CG No |
CG3799 |
Old CG No |
CG3799 |
| Synonyms |
BcDNA:GH03693, Exn, CG3799 |
| Accession No (Link to NCBI) |
NM_140685.4 |
| Inserted Chr. |
lll |
| Insertional Mutation |
|
| Phenotype induced by Act5C-GAL4 at 28 degrees |
lethal |
| Map Viewer |
|
Reference
[Please submit your publication]
|
Dourlen P, Fernandez-Gomez FJ, Dupont C, Grenier-Boley B, Bellenguez C, Obriot H, Caillierez R, Sottejeau Y, Chapuis J, Bretteville A, Abdelfettah F, Delay C, Malmanche N, Soininen H, Hiltunen M, Galas MC, Amouyel P, Sergeant N, Buée L, Lambert JC, Dermaut B.<br> Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology.<br> Mol Psychiatry (2017) 22(6) 874-883
[
PubMed ID = 27113998
]
[
RRC reference
]
|
| Comment |
|
| Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
| Primer Seq. 5' |
aaggcctacatggccggaccgATGTCGGCGTTGAATCGCAGC |
| Primer Seq. 3' |
aatctagaggtaccTGGGCGGATGCCGAGTGGTTT |
| Predicted Fragment Size |
500 |
| IR fragment full Seq |
0001 ATGTCGGCGT TGAATCGCAG CAATGGCCAG CGCCTCAGCT GCTCCGGCAN TCTGAGCAGC
0061 AGCGGcCATC CCGCCGATCC GGTGACCTTG CCCCGGAAAC GGCGACCTCG GGCTCGTGGC
0121 GAGGTCGGGG TCACCTGTCA GGGAAGCAGC ACCGTCNTAT CTCAACGGAC CCGTGTCCGC
0181 CGAACCCATT CGACCCGCTC CCGAACCCAT TTACCAAAAC GAAGCGGCAG CCATTAGCCA
0241 GCGCTGCAGT TACAGCCACC AACGAGCCCA AACTACTGAC CTCCATGCGA GTGACAGTAG
0301 CGGAGGGAGC CGAAAATGAC GCAAAGGTCA CCATGGAAGT GAGCACATTC GTAGATGACT
0361 CAGACCACTA CTACGAGACC CTGTCGCCAC TCGGAAACAA ACGCCATTCA ACACAGCTGG
0421 TGCgGCAGAG CCAGGATGGA AATCGGAGCG GAGGGGtgcG CTCCTCGNAC CGcCGGAGCA
0481 AAAACCAcNC NGCAGTCCGC CCA |
| in silico PCR Fragment |
0001 ATGTCGGCGT TGAATCGCAG CAATGGCCAG CGCCTCAGCT GCTCCGGCAG TCTGAGCAGC
0061 AGCGGCCATC CCGCCGATCC GGTGACCTTG CCCCGGAAAC GGCGACCTCG GGCTCGTGGC
0121 GAGGTCGGGG TCACCTGTCA GGGAAGCAGC ACCGTC-TAT CTCAACGGAC CCGTGTCCGC
0181 CGAACCCATT CGACCCGCTC CCGAACCCAT TTACCAAAAC GAAGCGGCAG CCATTAGCCA
0241 GCGCTGCAGT TACAGCCACC AACGAGCCC- AACTACTGAC CTCCATGCGA GTGACAGTAG
0301 CGGAGGGAGC CGAAAATGAC GCAAAGGTCA CCATGGAAGT GAGCACATTC GTAGATGACT
0361 CAGACCACTA CTACGAGACC CTGTCGCCAC TCGGAAACAA ACGCCATTCA ACACAGCTGG
0421 TGCGGCAGAG CCAGGATGGA AATCGGAGCG GAGGGGTGCG CTCCTCGCAC CGCCGGAGCA
0481 AAAACCACTC GGCA-TCCGC CCA |
| Assemble Data |
<PRE>
3799R-3.IR_full 1 ATGTCGGCGTTGAATCGCAGCAATGGCCAGCGCCTCAGCTGCTCCGGCA<span class="snp"><tt>N</tt></span>TCTGAGCAGC 60
|||||||||||||||||||||||||||||||||||||||||||||||||<span class="snp"><tt> </tt></span>||||||||||
3799R-3.in silico 1 ATGTCGGCGTTGAATCGCAGCAATGGCCAGCGCCTCAGCTGCTCCGGCA<span class="snp"><tt>G</tt></span>TCTGAGCAGC 60
3799R-3.IR_full 61 AGCGGCCATCCCGCCGATCCGGTGACCTTGCCCCGGAAACGGCGACCTCGGGCTCGTGGC 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3799R-3.in silico 61 AGCGGCCATCCCGCCGATCCGGTGACCTTGCCCCGGAAACGGCGACCTCGGGCTCGTGGC 120
3799R-3.IR_full 121 GAGGTCGGGGTCACCTGTCAGGGAAGCAGCACCGTC<span class="snp"><tt>N</tt></span>TATCTCAACGGACCCGTGTCCGC 180
||||||||||||||||||||||||||||||||||||<span class="snp"><tt> </tt></span>|||||||||||||||||||||||
3799R-3.in silico 121 GAGGTCGGGGTCACCTGTCAGGGAAGCAGCACCGTC<span class="snp"><tt>-</tt></span>TATCTCAACGGACCCGTGTCCGC 180
3799R-3.IR_full 181 CGAACCCATTCGACCCGCTCCCGAACCCATTTACCAAAACGAAGCGGCAGCCATTAGCCA 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3799R-3.in silico 181 CGAACCCATTCGACCCGCTCCCGAACCCATTTACCAAAACGAAGCGGCAGCCATTAGCCA 240
3799R-3.IR_full 241 GCGCTGCAGTTACAGCCACCAACGAGCCC<span class="snp"><tt>A</tt></span>AACTACTGACCTCCATGCGAGTGACAGTAG 300
|||||||||||||||||||||||||||||<span class="snp"><tt> </tt></span>||||||||||||||||||||||||||||||
3799R-3.in silico 241 GCGCTGCAGTTACAGCCACCAACGAGCCC<span class="snp"><tt>-</tt></span>AACTACTGACCTCCATGCGAGTGACAGTAG 300
3799R-3.IR_full 301 CGGAGGGAGCCGAAAATGACGCAAAGGTCACCATGGAAGTGAGCACATTCGTAGATGACT 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3799R-3.in silico 301 CGGAGGGAGCCGAAAATGACGCAAAGGTCACCATGGAAGTGAGCACATTCGTAGATGACT 360
3799R-3.IR_full 361 CAGACCACTACTACGAGACCCTGTCGCCACTCGGAAACAAACGCCATTCAACACAGCTGG 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3799R-3.in silico 361 CAGACCACTACTACGAGACCCTGTCGCCACTCGGAAACAAACGCCATTCAACACAGCTGG 420
3799R-3.IR_full 421 TGCGGCAGAGCCAGGATGGAAATCGGAGCGGAGGGGTGCGCTCCTCG<span class="snp"><tt>N</tt></span>ACCGCCGGAGCA 480
|||||||||||||||||||||||||||||||||||||||||||||||<span class="snp"><tt> </tt></span>||||||||||||
3799R-3.in silico 421 TGCGGCAGAGCCAGGATGGAAATCGGAGCGGAGGGGTGCGCTCCTCG<span class="snp"><tt>C</tt></span>ACCGCCGGAGCA 480
3799R-3.IR_full 481 AAAACCAC<span class="snp"><tt>N</tt></span>C<span class="snp"><tt>N</tt></span>GCA<span class="snp"><tt>G</tt></span>TCCGCCCA 503
||||||||<span class="snp"><tt> </tt></span>|<span class="snp"><tt> </tt></span>|||<span class="snp"><tt> </tt></span>||||||||
3799R-3.in silico 481 AAAACCAC<span class="snp"><tt>T</tt></span>C<span class="snp"><tt>G</tt></span>GCA<span class="snp"><tt>-</tt></span>TCCGCCCA 503
</PRE>
|
| Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
| cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
| 100 |
482 |
0 |
0 |
0 |
NM_168705.1 |
CG3799-RB, transcript variant B (CG3799), mRNA |
| 100 |
482 |
0 |
0 |
0 |
NM_168706.1 |
CG3799-RC, transcript variant C (CG3799), mRNA |
| 100 |
482 |
0 |
0 |
0 |
NM_140685.4 |
CG3799-RA, transcript variant A (CG3799), mRNA |
| 0 |
0 |
2 |
3 |
2 |
NM_141163.1 |
CG11226-RA (CG11226), mRNA |
| 0 |
0 |
2 |
2 |
4 |
NM_079877.2 |
CG17245-RA (plexB), mRNA |
| 0 |
0 |
2 |
2 |
4 |
NR_001596.1 |
CR32011, mRNA |
| 0 |
0 |
2 |
2 |
4 |
NR_001597.1 |
CR32010, mRNA |
| 0 |
0 |
2 |
2 |
4 |
NR_001598.1 |
CR32009, mRNA |
| 0 |
0 |
1 |
5 |
3 |
NM_132625.1 |
CG4351-RA (CG4351), mRNA |
| 0 |
0 |
1 |
4 |
4 |
NM_139371.1 |
CG13917-RA (CG13917), mRNA |
| 0 |
0 |
1 |
3 |
5 |
NM_078645.2 |
CG4252-RA (mei-41), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_168413.1 |
CG32062-RB, transcript variant B (CG32062), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_168412.1 |
CG32062-RD, transcript variant D (CG32062), mRNA |
| 0 |
0 |
1 |
3 |
3 |
NM_078824.2 |
CG4881-RA, transcript variant A (salr), mRNA |
| 0 |
0 |
1 |
3 |
3 |
NM_164965.1 |
CG4881-RB, transcript variant B (salr), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_168995.1 |
CG31528-RA (CG31528), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_144348.2 |
CG12135-RA (c12.1), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_132132.1 |
CG4557-RA (CG4557), mRNA |
| 0 |
0 |
0 |
6 |
2 |
NM_140017.1 |
CG5644-RA (CG5644), mRNA |
| 0 |
0 |
0 |
6 |
2 |
NM_058088.3 |
CG8730-RA (drosha), mRNA |
| 0 |
0 |
0 |
6 |
2 |
NM_164780.1 |
CG7392-RC, transcript variant C (Cka), mRNA |
| 0 |
0 |
0 |
6 |
2 |
NM_135333.2 |
CG7392-RA, transcript variant A (Cka), mRNA |
| 0 |
0 |
0 |
6 |
2 |
NM_164779.1 |
CG7392-RB, transcript variant B (Cka), mRNA |
| 0 |
0 |
0 |
6 |
2 |
NM_164781.1 |
CG7392-RD, transcript variant D (Cka), mRNA |
| 0 |
0 |
0 |
5 |
9 |
NM_140056.2 |
CG3891-RA (CG3891), mRNA |
| 0 |
0 |
0 |
5 |
4 |
NM_057245.2 |
CG6189-RA (l(1)1Bi), mRNA |
| 0 |
0 |
0 |
5 |
3 |
NM_080508.2 |
CG2152-RA (Pcmt), mRNA |
| 0 |
0 |
0 |
5 |
3 |
NM_134752.2 |
CG5561-RA (CG5561), mRNA |
| 0 |
0 |
0 |
4 |
2 |
NM_139976.1 |
CG6765-RA (CG6765), mRNA |
| 0 |
0 |
0 |
3 |
11 |
NM_140521.1 |
CG6498-RA (CG6498), mRNA |
|
|
Pathways (updated: 2024/04/26)
|
| KEGG Pathway |
|
|
|
